Prostascint imaging should be considered after a definitive diagnosis of localized prostate cancer , as proven by standard diagnostic investigations including chest x-ray , bone scan , CT scan , or MRI , which have been made prior to the initiation of definitive therapy in form of surgery or radiotherapy . Prostascint is not indicated in patients who are not at high risk for developing metastatic disease (Hinke et al , 1998 . In fact it is especially administered to those patients who are at a high risk...











SUBJECTS

